Gadoteridol

Also known as: Triautic acid

Drug #1910

Gadoteridol is a paramagnetic contrast medium used to provide clear picture during MRI(magnetic resonance imaging) which is a special type ofdiagnostic procedures.

← Previous drug Next drug →

Primary Characteristics

Gadoteridol is also known as Triautic acid.

It belongs to Gadolinium.

Molecular Weight: 558.69 · Solubility in Water: Freely Soluble · Non-proprietary name: Gadoteridol · pH: 6.5.

Pharmacokinetics

Distribution: Gadoteridol has a volume of distribution is 204 ± 58 ml/kg.

Elimination: plasma half-life is 1.57±0.08, renal excretion is 94%of dose excreted in 24 hours.

Indications

Gadoteridol is primarily indicated in conditions like Diagnostic procedures, Non ionic contrast medium.

Contraindications

Gadoteridol is contraindicated in conditions like Haemolytic anaemia, Renal impairment, Hypersensitivity to the drug.

Dosage

Gadoteridol's dosage details are as follows:

Dose	Single Dose	Frequency	Route	Instructions
Adult Dosage
0.2 ml/kg body weight	0.2 ml/kg body weight	—	IV	An additional dose up to 0.4ml/kg may be given upto 30 min
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

None recorded.

Side Effects

Gadoteridol produces potentially life-threatening effects which include Cardiovascular effect. Careful monitoring is needed with proper medical management.

Gadoteridol is known to cause more or less tolerable side effects which are usually transient. These include Diarrhea, Headache, Nausea and vomiting, vasodialation.

Warnings / Precautions

Gadoteridol should be given to pregnant mothers with caution. Care should also be taken in patints who are allergic to gadoteridol.

Available Brands

None recorded.

Storage Conditions

Gadoteridol should be stored .

Drug Classification

1.14.2 — Radiocontrast media